# SPRY (ARS Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> ARS Pharmaceuticals, Inc. reported $122.1M in revenue and a net loss of $199.9M for the trailing twelve months ended September 30, 2026 (up 16.0% year over year), with a -161.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/SPRY
- Markdown: https://convexityos.com/fundamentals/SPRY.md
- SEC CIK: 0001671858
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001671858&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $122.1M | +16.0% YoY |
| Operating Income | TTM | -$197.2M | -161.5% margin |
| Net Income | TTM | -$199.9M | -163.6% net margin |
| Diluted EPS | TTM | -$2.00 | Split-adjusted |
| Free Cash Flow | TTM | -$183.1M | -149.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $138.4M | Total debt: $121.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $84.28M | $89.15M | $30K | $1.32M | $5.51M | -- |
| Cost of Revenue | -- | -- | $0 | -- | -- | -- |
| **Gross Profit** | -- | -- | $30K | -- | -- | -- |
| Research & Development | $13.18M | $19.58M | $20.27M | $18.38M | $20.27M | $24.58M |
| Selling, General & Admin | $230.1M | $71.67M | $47.28M | $603K | -- | -- |
| Total Operating Expenses | $263.7M | $92.23M | $67.55M | $36.83M | $24.96M | $32.92M |
| **Operating Income** | -$179.4M | -$3.08M | -$67.52M | -$35.52M | -$19.45M | -$32.92M |
| **EBITDA** | -$178.1M | -$3.00M | -$67.42M | -$35.20M | -$19.24M | -$32.28M |
| Income Before Tax | -$171.4M | $8.29M | -$54.37M | -- | -- | -- |
| Income Tax Expense | -$80K | $288K | $0 | $0 | $0 | $0 |
| **Net Income** | -$171.3M | $8.00M | -$54.37M | -$34.68M | -$20.24M | -$32.95M |
| Basic EPS | -$1.74 | $0.08 | -$0.57 | -$0.87 | -$0.70 | -$11.33 |
| **Diluted EPS** | -$1.74 | $0.08 | -$0.57 | -$0.87 | -$0.70 | -$11.33 |
| Basic Shares Outstanding | 98.6M | 96.9M | 95.2M | 40.0M | 28.9M | 2.9M |
| Diluted Shares Outstanding | 98.6M | 102.4M | 95.2M | 40.0M | 28.9M | 2.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $37.71M | $33.66M | $22.68M | $28.09M | $32.50M | $15.72M | $7.97M | $86.58M |
| Research & Development | $18.26M | $4.70M | $4.34M | $3.44M | $2.75M | $4.04M | $2.95M | $3.03M |
| Selling, General & Admin | $43.52M | $77.58M | $72.20M | $59.95M | $74.75M | $54.31M | $41.10M | $35.49M |
| Total Operating Expenses | $71.88M | $95.12M | $82.83M | $69.55M | $85.69M | $63.33M | $45.15M | $39.38M |
| **Operating Income** | -$34.17M | -$61.47M | -$60.15M | -$41.47M | -$53.19M | -$47.61M | -$37.18M | $47.20M |
| **EBITDA** | -$33.76M | -$61.05M | -$59.75M | -$41.05M | -$52.80M | -$47.34M | -$36.90M | $47.23M |
| **Net Income** | -$35.59M | -$62.34M | -$60.62M | -$41.32M | -$51.15M | -$44.88M | -$33.94M | $49.93M |
| Basic EPS | -$0.36 | -$0.63 | -$0.61 | -- | -$0.52 | -$0.46 | -$0.35 | -- |
| **Diluted EPS** | -$0.36 | -$0.63 | -$0.61 | -- | -$0.52 | -$0.46 | -$0.35 | -- |
| Basic Shares Outstanding | 99.7M | 99.3M | 99.3M | -- | 98.8M | 98.4M | 98.1M | -- |
| Diluted Shares Outstanding | 99.7M | 99.3M | 99.3M | -- | 98.8M | 98.4M | 98.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.32M | $50.82M | $70.97M | $210.5M | $60.06M | $386.6M |
| Short-Term Investments | $203.7M | $263.2M | $157.4M | $63.86M | $0 | -- |
| **Cash & Short-Term Investments** | $245.0M | $314.0M | $228.4M | $274.4M | $60.06M | $386.6M |
| Accounts Receivable, Net | $25.35M | $8.18M | $0 | -- | -- | -- |
| Inventory | $31.42M | $10.52M | $0 | -- | -- | -- |
| **Total Current Assets** | $284.9M | $334.3M | $231.7M | $277.7M | $60.73M | $390.7M |
| Property, Plant & Equipment, Net | $2.46M | $1.07M | $574K | $329K | $72K | $1.62M |
| Intangible Assets | $14.45M | $7.37M | $0 | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | $64.78M | $0 |
| Other Non-Current Assets | -- | -- | -- | $0 | -- | -- |
| **Total Non-Current Assets** | $42.76M | $16.86M | $1.46M | $3.73M | $716K | $4.15M |
| **Total Assets** | $327.7M | $351.2M | $233.2M | $281.4M | $61.45M | $394.8M |
| Accounts Payable | $5.72M | $9.87M | $759K | $1.66M | $1.79M | $2.58M |
| Deferred Revenue (Current) | $609K | $557K | $0 | $283K | $1.46M | -- |
| Other Current Liabilities | $588K | $42K | -- | -- | -- | -- |
| **Total Current Liabilities** | $39.15M | $23.44M | $2.39M | $5.44M | $8.19M | $9.60M |
| Long-Term Debt | $96.37M | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $1.13M | $1.53M | $0 | $2.85M | $3.00M | -- |
| **Total Non-Current Liabilities** | $174.2M | $70.92M | $37K | $3.10M | $8.49M | $2.33M |
| **Total Liabilities** | $213.4M | $94.36M | $2.43M | $8.55M | $16.68M | $11.93M |
| **Total Debt (incl. Leases)** | $96.37M | $42K | $274K | $481K | $5.85M | $3.22M |
| Common Stock | $10K | $10K | $10K | $9.0K | $3.0K | $3.0K |
| Retained Earnings | -$294.6M | -$123.3M | -$131.3M | -$76.94M | -$42.26M | -$96.73M |
| Accumulated Other Comp. Income | $125K | $220K | $49K | $407K | $0 | $0 |
| **Total Stockholders' Equity** | $114.3M | $256.8M | $230.8M | $272.9M | -$31.27M | -$14.05M |
| Total Equity | $114.3M | $256.8M | $230.8M | $272.9M | -$31.27M | -$14.05M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.62M | $8.16M | $24.32M | $41.32M | $59.56M | $51.54M | $39.86M | $50.82M |
| Short-Term Investments | $112.7M | $135.7M | $176.6M | $203.7M | $228.7M | $188.6M | $235.9M | $263.2M |
| **Cash & Short-Term Investments** | $138.4M | $143.8M | $201.0M | $245.0M | $288.2M | $240.1M | $275.7M | $314.0M |
| Accounts Receivable, Net | $52.76M | $46.84M | $28.66M | $25.35M | $36.45M | $25.13M | $9.30M | $8.18M |
| Inventory | $33.43M | $30.73M | $32.04M | $31.42M | $21.43M | $22.11M | $7.27M | $10.52M |
| **Total Current Assets** | $211.0M | $211.5M | $245.2M | $284.9M | $338.9M | $281.4M | $303.9M | $334.3M |
| Property, Plant & Equipment, Net | $1.93M | $2.08M | $2.29M | $2.46M | $1.21M | $1.07M | $1.07M | $1.07M |
| Intangible Assets | $13.62M | $13.90M | $14.18M | $14.45M | $14.73M | $12.97M | $7.24M | $7.37M |
| **Total Non-Current Assets** | $40.46M | $37.98M | $42.34M | $42.76M | $33.94M | $32.04M | $23.46M | $16.86M |
| **Total Assets** | $251.5M | $249.5M | $287.6M | $327.7M | $372.8M | $313.5M | $327.3M | $351.2M |
| Accounts Payable | $5.42M | $5.20M | $4.71M | $5.72M | $8.38M | $15.56M | $4.09M | $9.87M |
| Deferred Revenue (Current) | $511K | $535K | $757K | $609K | $526K | $746K | $540K | $557K |
| Other Current Liabilities | $599K | $596K | $592K | $588K | -- | -- | -- | $42K |
| **Total Current Liabilities** | $64.90M | $60.86M | $49.61M | $39.15M | $50.88M | $45.60M | $27.62M | $23.44M |
| Long-Term Debt | $121.8M | $96.68M | $96.52M | $96.37M | $96.23M | -- | -- | $0 |
| Deferred Revenue (Non-Current) | $1.05M | $1.11M | $978K | $1.13M | $1.27M | $1.10M | $1.34M | $1.53M |
| **Total Non-Current Liabilities** | $198.5M | $176.1M | $176.7M | $174.2M | $174.3M | $75.55M | $70.72M | $70.92M |
| **Total Liabilities** | $263.4M | $237.0M | $226.3M | $213.4M | $225.1M | $121.2M | $98.34M | $94.36M |
| **Total Debt (incl. Leases)** | $121.8M | $96.68M | $96.52M | $96.37M | $97.76M | $1.66M | $73K | $42K |
| Common Stock | $10K | $10K | $10K | $10K | $10K | $10K | $10K | $10K |
| Retained Earnings | -$453.1M | -$417.6M | -$355.2M | -$294.6M | -$253.3M | -$202.1M | -$157.2M | -$123.3M |
| Accumulated Other Comp. Income | -$104K | -$140K | -$96K | $125K | -$7.0K | -$46K | $72K | $220K |
| **Total Stockholders' Equity** | -$11.96M | $12.51M | $61.31M | $114.3M | $147.7M | $192.3M | $229.0M | $256.8M |
| Total Equity | -$11.96M | $12.51M | $61.31M | $114.3M | $147.7M | $192.3M | $229.0M | $256.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$171.3M | $8.00M | -$54.37M | -$34.68M | -$20.24M | -$32.95M |
| Depreciation & Amortization | $1.37M | $79K | $100K | $319K | $213K | $637K |
| Stock-Based Compensation | $22.09M | $14.53M | $9.23M | $5.84M | $2.83M | $2.64M |
| Change in Receivables | -$17.20M | -$8.18M | $0 | -- | -- | -- |
| Change in Inventory | -$21.99M | -$5.95M | $0 | -- | -- | -- |
| **Operating Cash Flow** | -$170.9M | $13.55M | -$59.27M | -$40.08M | -$17.56M | -$31.20M |
| Capital Expenditure | -$339K | -$563K | -$175K | -$199K | -$55K | -$917K |
| **Free Cash Flow** | -$171.2M | $12.98M | -$59.44M | -$40.28M | -$17.62M | -$32.11M |
| Purchases of Investments | -- | -- | -- | -- | -$65.11M | $0 |
| **Investing Cash Flow** | $56.77M | -$106.1M | -$87.18M | -$199K | -$55K | -$917K |
| **Financing Cash Flow** | $104.6M | $72.40M | $6.90M | $190.7M | $53.16M | $408.5M |
| **Net Change in Cash** | -$9.50M | -$20.15M | -$139.5M | $150.5M | $35.54M | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$35.59M | -$62.34M | -$60.62M | -$41.32M | -$51.15M | -$44.88M | -$33.94M | $49.93M |
| Depreciation & Amortization | $415K | $416K | $397K | $417K | $391K | $279K | $280K | $29K |
| Stock-Based Compensation | $8.12M | $12.39M | $7.42M | $5.74M | $5.69M | $5.37M | $5.30M | $4.26M |
| Change in Receivables | -$5.89M | -$20.63M | -$839K | $11.18M | -$14.01M | -$13.25M | -$1.13M | -$7.40M |
| Change in Inventory | -$2.28M | $13K | -$294K | -$9.72M | $963K | -$4.78M | -$8.45M | -$5.76M |
| **Operating Cash Flow** | -$33.71M | -$60.93M | -$44.95M | -$43.48M | -$47.05M | -$39.59M | -$40.74M | $42.00M |
| Capital Expenditure | $0 | $0 | $0 | $0 | -$197K | -$51K | -$91K | -$302K |
| **Free Cash Flow** | -$33.71M | -$60.93M | -$44.95M | -$43.48M | -$47.24M | -$39.64M | -$40.83M | $41.70M |
| **Investing Cash Flow** | $23.41M | $41.57M | $27.79M | $24.11M | -$44.98M | $48.57M | $29.06M | -$101.8M |
| **Financing Cash Flow** | $27.76M | $3.20M | $159K | $1.13M | $100.0M | $2.70M | $725K | $70.92M |
| **Net Change in Cash** | $17.46M | -$16.16M | -$17.00M | -$18.24M | $8.02M | $11.68M | -$10.95M | $11.16M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | 100.0% | -- | -- | -- |
| **Operating Margin** | -212.9% | -3.5% | -225066.7% | -2698.8% | -353.3% | -- |
| **Net Profit Margin** | -203.3% | 9.0% | -181216.7% | -2635.4% | -367.7% | -- |
| Return on Equity (ROE) | -149.9% | 3.1% | -23.6% | -12.7% | -- | -- |
| Return on Assets (ROA) | -52.3% | 2.3% | -23.3% | -12.3% | -32.9% | -8.3% |
| Current Ratio | 7.28x | 14.26x | 96.92x | 51.01x | 7.42x | 40.69x |
| Quick Ratio | 6.48x | 13.81x | 96.92x | 50.40x | 7.34x | 40.26x |
| Debt to Equity | 0.84x | 0.00x | 0.00x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -5.5% | +297063.3% | -97.7% | -76.1% | -- | -- |
| **Net Income Growth (YoY)** | -2241.8% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -2275.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -1361.2% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -1418.5% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -161.5% | -185.0% | -204.5% | -212.9% | -63.6% | -52.8% | -27.9% | -3.5% |
| **Net Profit Margin** | -163.6% | -184.2% | -200.0% | -203.3% | -56.1% | -42.7% | -16.1% | 9.0% |
| Return on Equity (ROE) | -- | -1721.8% | -322.9% | -149.9% | -54.2% | -25.0% | -6.8% | 3.1% |
| Return on Assets (ROA) | -79.5% | -86.3% | -68.8% | -52.3% | -21.5% | -15.3% | -4.8% | 2.3% |
| Current Ratio | 3.25x | 3.48x | 4.94x | 7.28x | 6.66x | 6.17x | 11.00x | 14.26x |
| Quick Ratio | 2.74x | 2.97x | 4.30x | 6.48x | 6.24x | 5.69x | 10.74x | 13.81x |
| Debt to Equity | -- | 7.73x | 1.57x | 0.84x | 0.66x | 0.01x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | +16.0% | +114.2% | +184.5% | -67.6% | +1471.6% | +3043.4% | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -187.9% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -182.8% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -203.5% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -204.3% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
